State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation. | Biotechnol Prog;28(4): 899-916, 2012 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

State-of-the-art in downstream processing of monoclonal antibodies: process trends in design and validation.

Marichal-Gallardo, P A; Alvarez, M M.

Affiliation

Marichal-Gallardo PA; Centro de Biotecnología-FEMSA, Tecnológico de Monterrey at Monterrey, Av. Eugenio Garza Sada 2501, 64849 Monterrey, NL, México.

Biotechnol Prog ; 28(4): 899-916, 2012 Jul.

Article in En | MEDLINE | ID: mdl-22641473

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biotechnology / Antibodies, Monoclonal Type of study: Evaluation_studies Limits: Animals / Humans Language: En Journal: Biotechnol Prog Journal subject: BIOTECNOLOGIA Year: 2012 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biotechnology / Antibodies, Monoclonal Type of study: Evaluation_studies Limits: Animals / Humans Language: En Journal: Biotechnol Prog Journal subject: BIOTECNOLOGIA Year: 2012 Document type: Article Country of publication: